Alzheimer Society of Canada's 28th National Conference
Posted on November 8, 2012 by DementiaGuide
WRAP-UP - published by Alzheimer Society of Canada
For three days this November, more than 450 delegates from across Canada and the world came together at the Alzheimer Society of Canada's 28th National Conference, Alzheimer Research and Innovation: Yesterday, Today and Tomorrow.
Held in Toronto, the conference featured rewowned Canadian researchers, clinicians, health professionals and educators reporting on the latest advances in all areas of Alzheimer's disease research and support. This included sessions on causes and risk factors; diagnosis and treatment; mild cognitive impairment; as well as quality of life, caregiving, family and other social issues related to the disease.
This diverse program explored the challenges of Alzheimer's disease, addressed the issues facing people with the illness, and presented ways to help change the future of the disease.
Other highlights included the Andreae Alzheimer Lecture featuring this year's guest speaker Art Linkletter, and the powerful, researched based play "I'm Still Here". The play, presented by actors from Ryerson University's ACT II STUDIO, represented a realistic portrayal of the experience of dementia from the perspectives of those living with the disease.
The closing plenary session featured a two hour panel discussion from five leading Canadian US researchers, as well as an Alzheimer advocate. Moderated by Dr. Jack Diamond, scientific director of the Alzheimer Society of Canada, the group tackled issues such as the effectiveness of current treatments, social issues related to the disease, what is happening today in research, and what we can expect in the next ten years.
We would like to acknowledge the generous support we have received from our sponsors:
Pfizer Canada Inc.
Lundbeck Canada Inc.
Novartis Pharmaceuticals Canada Inc.
CIHR Institute of Aging
Thank you for helping us share critical Alzheimer's insights and important advances in research.